A Decade After the KDOQI CKD Guidelines: A Perspective From Mexico

The impact after a decade of KDOQI (Kidney Disease Outcomes Quality Initiative) chronic kidney disease (CKD) guidelines1 in Mexico is difficult to assess because outcomes data are very limited. Indirect evidence suggests that the guidelines' terminology and therapeutic target recommendations have been widely disseminated among nephrologists, as judged by the content of conferences presented at annual meetings of the Mexican nephrological societies. There is only one study that has specifically addressed adherence to mineral metabolism guidelines in the Mexican population, but it is still unpublished (R.P., unpublished data, 2007). In this study, 753 prevalent dialysis patients were examined at baseline and after at least 12 months. The percentages of patients who had serum phosphorus, calcium, and parathyroid hormone values within the recommended KDOQI target were 35%, 32%, and 12%, respectively, and the most frequent abnormalities were hyperphosphatamia, hypercalcemia, and low parathyroid hormone level. ©American Journal of Kidney Diseases © 2012 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.